Takashi Sugita, Mami Tajima, Hisae Tsubuku, Ryoji Tsuboi, Akemi Nishikawa: A New Calcineurin Inhibitor, Pimecrolimus, Inhibits the Growth of Malassezia spp. In: Antimicrobial Agents and Chemotherapy. Band50, Nr.8, August 2006, S.2897–2898, doi:10.1128/AAC.00687-06, PMID 16870799, PMC 1538684 (freier Volltext).
M. Grassberger, M. Steinhoff, D. Schneider, T. A. Luger: Pimecrolimus – an anti‐inflammatory drug targeting the skin. In: Experimental Dermatology. Band13, Nr.12, Dezember 2004, S.721–730, doi:10.1111/j.0906-6705.2004.00269.x.
David J. Margolis, Katrina Abuabara, Ole J. Hoffstad, Joy Wan, Denise Raimondo: Association Between Malignancy and Topical Use of Pimecrolimus. In: JAMA dermatology. Band151, Nr.6, 1. Juni 2015, S.594–599, doi:10.1001/jamadermatol.2014.4305, PMID 25692459, PMC 4465068 (freier Volltext).
Takashi Sugita, Mami Tajima, Hisae Tsubuku, Ryoji Tsuboi, Akemi Nishikawa: A New Calcineurin Inhibitor, Pimecrolimus, Inhibits the Growth of Malassezia spp. In: Antimicrobial Agents and Chemotherapy. Band50, Nr.8, August 2006, S.2897–2898, doi:10.1128/AAC.00687-06, PMID 16870799, PMC 1538684 (freier Volltext).
Topical pimecrolimus is an effective treatment for balanitis circinata erosiva. PMID 16207202
David J. Margolis, Katrina Abuabara, Ole J. Hoffstad, Joy Wan, Denise Raimondo: Association Between Malignancy and Topical Use of Pimecrolimus. In: JAMA dermatology. Band151, Nr.6, 1. Juni 2015, S.594–599, doi:10.1001/jamadermatol.2014.4305, PMID 25692459, PMC 4465068 (freier Volltext).